Alogliptin antidiabetic drugs  

SYR-322 - SYR322 - SYR 322      

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultcardiovascular eventsCardiovascular death

diabetes type 2  

Seino, 2011      NCTalogliptin -
Seino, 2011     alogliptin -
Bosi , 2011      NCTalogliptin -
Kaku, 2011     alogliptin -
Rosenstock, 2010      NCTalogliptin -
Rosenstock, 2009      NCTalogliptin -
Pratley, 2009      NCTalogliptin -
Pratley, 2009      NCTalogliptin -
DeFronzo , 2008      NCTalogliptin -
EXAMINE, 2011        NCTalogliptinplacebonegative-4%-20%
EXAMINE, 2013      NCTalogliptinplaceboLow risk of bias negative-4%-15%
Nauck, 2009      NCTalogliptinplacebo (add on MET)Low risk of bias negative